These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2161770)

  • 1. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
    Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.
    Kelbaek H; Linde J; Nielsen SL
    Eur J Nucl Med; 1988; 14(12):621-3. PubMed ID: 3243309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of granulocyte concentration on leukocyte labelling efficiency with 99mTc-HMPAO.
    Ballinger JR; Proulx A; Gerson B; Gulenchyn KY
    Int J Rad Appl Instrum B; 1990; 17(4):443. PubMed ID: 2387752
    [No Abstract]   [Full Text] [Related]  

  • 8. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control.
    Bassa P; García Garzón JR; Piera C; Pavía A; Minoves M; Moragas M; Pavía J; Lomeña F; Setoain J
    Nucl Med Biol; 1994 Oct; 21(7):963-7. PubMed ID: 9234351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m exametazime (99mTc-HMPAO)-labeled white blood cells: a high efficiency multidose procedure.
    Ozker K; Collier BD; Hellman RS; Isitman AT; Uzum F; Steffel FG
    Eur J Nucl Med; 1995 Feb; 22(2):182-3. PubMed ID: 7758507
    [No Abstract]   [Full Text] [Related]  

  • 10. Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.
    Vanlić-Razumenić N; Pujić N; Dedović N; Kostić K; Nastić-Mirić D
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):251-6. PubMed ID: 1629013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kit for labelling erythrocytes or leukocytes with technetium-99m.
    Proulx A; Gerson B; Ballinger JR; Gulenchyn KY
    Int J Rad Appl Instrum B; 1990; 17(5):515-7. PubMed ID: 2391248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiography and density gradient separation of technetium-99m-exametazime (HMPAO) labelled leucocytes reveals selectivity for eosinophils.
    Puncher MR; Blower PJ
    Eur J Nucl Med; 1994 Nov; 21(11):1175-82. PubMed ID: 7859768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and functional status of leukocytes labelled with 99m technetium HMPAO.
    De Labriolle-Vaylet C; Linhart NC; Petiet A; Bok B
    Prog Clin Biol Res; 1990; 355():119-29. PubMed ID: 2177895
    [No Abstract]   [Full Text] [Related]  

  • 14. [99mTc-HMPAO labeling of leukocytes and thrombocytes. Characteristics and diagnostic consequences].
    Becker W; Börner W
    Rofo; 1988 Jan; 148(1):69-74. PubMed ID: 2829311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
    García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
    Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
    Papós M; Láng J; Rajtár M; Csernay L
    Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
    [No Abstract]   [Full Text] [Related]  

  • 18. Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results.
    Becker W; Borst U; Krahe T; Börner W
    Eur J Nucl Med; 1989; 15(6):296-301. PubMed ID: 2767079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent.
    Kao CH; Huang WT; Tsai CS
    Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
    Danpure HJ; Osman S; Carroll MJ
    Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.